{"pageContent": "Purpose: To assess the performance of EAU risk classification in PCa patients according to the biopsy pathway (standard versus MRI guided) and to develop a new, more accurate, targeted biopsy (TB)-based classification.", "metaData": {"source": "EBRT less effective for early-stage prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/17436421/"}}